T3	Gene_or_gene_product 58 92	vascular endothelial growth factor
T6	Gene_or_gene_product 200 234	vascular endothelial growth factor
T7	Gene_or_gene_product 236 240	VEGF
T8	Cell 246 262	endothelial cell
T12	Drug_or_compound 468 477	alinidine
T15	Tissue 734 760	Left ventricular capillary
T17	Drug_or_compound 812 821	alinidine
T19	Drug_or_compound 903 912	alinidine
T20	Multi-tissue_structure 940 956	Left ventricular
T22	Drug_or_compound 1028 1037	alinidine
T25	Tissue 1098 1107	capillary
T27	Gene_or_gene_product 1124 1128	VEGF
T28	Gene_or_gene_product 1229 1233	VEGF
T30	Drug_or_compound 1256 1265	alinidine
T32	Gene_or_gene_product 1373 1377	VEGF
T34	Drug_or_compound 1442 1451	alinidine
T37	Gene_or_gene_product 1490 1494	bFGF
T39	Drug_or_compound 1519 1528	alinidine
T40	Gene_or_gene_product 1564 1568	VEGF
T43	Gene_or_gene_product 1681 1685	VEGF
T2	Multi-tissue_structure 681 689	Arterial
T9	Organ 344 349	heart
T1000	Organism 425 429	rats
T1001	Organism 1274 1278	rats
T48	Gene_or_gene_product 1373 1401	VEGF-neutralizing antibodies
T54	Multi-tissue_structure 20 28	coronary
T55	Multi-tissue_structure 104 112	coronary
T1	Blood_vessel_development 29 41	angiogenesis
T4	Blood_vessel_development 113 125	angiogenesis
T10	Blood_vessel_development 296 308	angiogenesis
T36	Blood_vessel_development 1463 1475	angiogenesis
T42	Blood_vessel_development 1593 1603	angiogenic
T45	Blood_vessel_development 1697 1709	angiogenesis
T5	Positive_regulation 313 324	upregulated
E5	Positive_regulation:T5 Theme:T6
T11	Planned_process 433 446	administering
E11	Planned_process:T11 Instrument:T12 Theme:T1000
T13	Positive_regulation 787 796	increased
E13	Positive_regulation:T13 Theme:T15 Cause:E16
T16	Planned_process 822 836	administration
E16	Planned_process:T16 Instrument:T17
T18	Planned_process 913 922	treatment
E18	Planned_process:T18 Instrument:T19
T21	Planned_process 1038 1047	treatment
E21	Planned_process:T21 Instrument:T22
T26	Positive_regulation 1134 1143	increased
E26	Positive_regulation:T26 Theme:T27
T29	Planned_process 1266 1273	treated
E29	Planned_process:T29 Instrument:T30 Theme:T1001
T31	Planned_process 1360 1369	Injection
E31	Planned_process:T31 Instrument:T48
T38	Planned_process 1529 1538	treatment
E38	Planned_process:T38 Instrument:T39
*	Equiv T6 T7
T23	Positive_regulation 12 19	induced
E1	Positive_regulation:T23 Theme:E19
T33	Positive_regulation 45 54	dependent
E2	Positive_regulation:T33 Theme:E19 Cause:T3
A1	Speculation E5
T35	Positive_regulation 844 852	increase
E3	Positive_regulation:T35 Theme:T15
T41	Positive_regulation 877 885	increase
E4	Positive_regulation:T41 Theme:T15
T44	Positive_regulation 1086 1094	increase
E6	Positive_regulation:T44 Theme:T25
T46	Negative_regulation 1174 1182	declined
E7	Negative_regulation:T46 Theme:T27
T47	Positive_regulation 1314 1323	increased
E8	Positive_regulation:T47 Theme:T28
T49	Negative_regulation 1434 1441	blocked
E9	Negative_regulation:T49 Cause:E31 Theme:E23
T50	Positive_regulation 1452 1462	stimulated
E10	Positive_regulation:T50 Cause:T34 Theme:E23
T51	Regulation 1508 1515	altered
E12	Regulation:T51 Cause:E38 Theme:T37
A2	Negation E12
T52	Regulation 1569 1585	plays a key role
E15	Regulation:T52 Cause:T40 Theme:E25
T53	Regulation 1686 1696	associated
E17	Regulation:T53 Cause:T43 Theme:E27
E19	Blood_vessel_development:T1 Theme:T54
E20	Blood_vessel_development:T4 Theme:T55
E22	Blood_vessel_development:T10 
E23	Blood_vessel_development:T36 
E25	Blood_vessel_development:T42 
E27	Blood_vessel_development:T45 
